OABI CIK: 1846253

OmniAb, Inc.

  • United States
  • Healthcare
  • Biotech
Metrics score locked — part of Premium
FY22
FY22
FY23
FY24
FY25
FY22 – FY25

Assets

(positive)
Change from FY22 to FY25
millions USD
FY22:
100
FY22:
125
FY23:
94.9
FY24:
68.1
FY25:
65.3
(positive)
Change from FY22 to FY25
millions USD
FY22:
293
FY22:
296
FY23:
280
FY24:
257
FY25:
236
Total assets
Change from FY22 to FY25
millions USD
FY22:
393
FY22:
421
FY23:
375
FY24:
326
FY25:
301

Liabilities & Equity

(negative)
Change from FY22 to FY25
millions USD
FY22:
12.3
FY22:
26.0
FY23:
23.1
FY24:
15.1
FY25:
16.3
(negative)
Change from FY22 to FY25
millions USD
FY22:
54.9
FY22:
53.8
FY23:
37.5
FY24:
22.9
FY25:
17.6
(positive)
Change from FY22 to FY25
millions USD
FY22:
–
FY22:
341
FY23:
315
FY24:
288
FY25:
267
Total liabilities & equity
Change from FY22 to FY25
millions USD
FY22:
–
FY22:
421
FY23:
375
FY24:
326
FY25:
301

All amounts in millions USD Data source:SEC EDGAR